Healthcare Intelligence
Genomics & Precision Medicine
Real-time intelligence, expert analysis, and verified research for the Genomics & Precision Medicine industry. Stay ahead in 3 minutes a day.
Stay ahead of Genomics & Precision Medicine in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
Synnovis & SOPHiA GENETICS Bring Blood-based Cancer Testing to UK
Partnership launches liquid biopsy testing for lung and breast cancer patients across UK, enabling treatment 2 weeks earlier.
Read full articleIsomorphic Labs Raises $2.1B to Scale AI Drug Design Platform
AI drug discovery company secures massive funding led by Thrive Capital to accelerate its drug design engine and pipeline.
Read full articlePrognomiQ Blood Test Shows 89% Sensitivity for Lung Cancer Detection
ProVue Lung test demonstrates 83% sensitivity for Stage I lung cancer in real-world study, offering breakthrough early detection.
Read full articleUK Invests £4.75M in World's First ME/CFS Genomics Study
Government funds SequenceME program to sequence 6,000 patient genomes, creating first genetic map of chronic fatigue syndrome.
Read full articleRibo Partners with Insilico Medicine for AI-Powered siRNA Development
Strategic collaboration combines Ribo's siRNA expertise with Insilico's AI platform to accelerate oligonucleotide drug discovery.
Read full articleSynnovis & SOPHiA GENETICS Bring Blood-based Cancer Testing to UK
Partnership launches liquid biopsy testing for lung and breast cancer patients across UK, enabling treatment 2 weeks earlier.
Read full articleIsomorphic Labs Raises $2.1B to Scale AI Drug Design Platform
AI drug discovery company secures massive funding led by Thrive Capital to accelerate its drug design engine and pipeline.
Read full articlePrognomiQ Blood Test Shows 89% Sensitivity for Lung Cancer Detection
ProVue Lung test demonstrates 83% sensitivity for Stage I lung cancer in real-world study, offering breakthrough early detection.
Read full articleUK Invests £4.75M in World's First ME/CFS Genomics Study
Government funds SequenceME program to sequence 6,000 patient genomes, creating first genetic map of chronic fatigue syndrome.
Read full articleRibo Partners with Insilico Medicine for AI-Powered siRNA Development
Strategic collaboration combines Ribo's siRNA expertise with Insilico's AI platform to accelerate oligonucleotide drug discovery.
Read full articleStay ahead of Genomics & Precision Medicine in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.